Direkt zum Inhalt
Merck
  • Prevalence of high-level mupirocin resistance among meticillin-resistant Staphylococcus aureus isolates in a tertiary care hospital in Singapore.

Prevalence of high-level mupirocin resistance among meticillin-resistant Staphylococcus aureus isolates in a tertiary care hospital in Singapore.

The Journal of hospital infection (2012-08-03)
S Choudhury, P U Krishnan, B Ang
ZUSAMMENFASSUNG

High-level resistance to mupirocin in meticillin-resistant Staphylococcus aureus (MRSA) jeopardizes its role in nasal decolonization protocols. We carried out a study in 2010 to determine the prevalence of high-level mupirocin resistance in our tertiary-care hospital. The prevalence of high-level resistance to mupirocin in MRSA in this hospital was 11%. There was also complete agreement between the genotypic and phenotypic methods of detection of high-level mupirocin resistance in 24 of the screening isolates.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Mupirocin, ≥92% (HPLC), powder
Sigma-Aldrich
Lithium-Mupirocin Lithiumsalz, ≥95.0% (HPLC)
Millipore
Lithium-Mupirocin-Supplement, suitable for microbiology,

Selectively inhibits the growth of lactic acid bacteria